Dr Jason Johnson is a British Heart Foundation Senior Research Fellow, Associate Professor of Cardiovascular Pathology, and leads the Laboratory of Cardiovascular Pathology at Bristol Medical School, University of Bristol. He has a long-standing interest in the pathophysiology of numerous cardiovascular pathologies including atherosclerosis, aortic aneurysms, and restenosis. His studies include a marriage of basic science and translational cardiovascular research with the goal of facilitating the development and deployment of novel therapies to combat the aforementioned cardiovascular diseases, alongside the identification of potential biomarkers of disease progression. He has developed a novel ex vivo human model of aneurysm that will hopefully supplant the requirement for animal studies.
Scientist: Jason Johnson
Alternative approaches to animal testing
In 1959, The Principles of Humane Experimental Technique was published by Russell and Burch, introducing the 3Rs concept (replacement, reduction, and refinement) regarding animal use in the scientific community. Just over 60 years later, it is timely to review progress to date and the future outlook regarding alternative approaches to animal testing.
A scientist’s opinion : Interview with Dr Jason Johnson about animal testing
Interview with Dr Jason Johnson, British Heart Foundation Senior Research Fellow, Associate Professor of Cardiovascular Pathology, and leads the Laboratory of Cardiovascular Pathology at Bristol Medical School, University of Bristol. As a scientist, in general do you find that the 3Rs concept is something that is routinely thought of when discussing experimental plans, or is ...
